Evaluation on the Use of Afatinib Alone or Combined with Other Drugs in Clinical Trials

by Lian-ke LIU, Yong-qian SHU
Published 2016-06-01

Application of 18F-FDG PET/CT in Rare Metastatic Locations of Esophageal Carcinoma

by Lan MA, Dan GUAN, Qi-yong DING, Yong-qian SHU, Lian-ke LIU
Published 2015-06-01

Co-mutations in tumor immune microenvironment and immunotherapy

by Ling Ma, Ling-Jun Zhu, Zi-Jie Xu, Yong-Qian Shu, Pei-Fang Wei
Published 2021-05-01

Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer

by Jia-Li Xu, Xin-Zhu Wang, Hu-Ning Jiang, Yi Chen, Rong Wang, Yong-Qian Shu, Pei-Fang Wei.
Published 2020-10-01

Erratum to: Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell proliferation by epigenetic silencing of KLF2

by Ming-de Huang, Wen-ming Chen, Fu-zhen Qi, Rui Xia, Ming Sun, Tong-peng Xu, Li Yin, Er-bao Zhang, Wei De, Yong-qian Shu
Published 2017-07-01

JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis

by Jun-Jie Chen, Yan-Lin Ren, Chuan-Jun Shu, Yi Zhang, Min-Juan Chen, Jin Xu, Jin Li, Ai-Ping Li, Dong-Yin Chen, Jing-Dong He, Yong-Qian Shu, Jian-Wei Zhou
Published 2020-06-01

Expert consensus on maintenance treatment for metastatic colorectal cancer in China

by Rui-Hua Xu, Lin Shen, Jin Li, Jian-Ming Xu, Feng Bi, Yi Ba, Li Bai, Yong-Qian Shu, Tian-Shu Liu, Yu-Hong Li, Chun-Mei Bai, Xiang-Lin Yuan, Jun Zhang, Gong Chen, Ai-Ping Zhou, Ying Yuan, Xi-Jing Wang, Xiao-Ping Qian, Yan-Hong Deng
Published 2016-01-01